Mixed bacterial infection model of sepsis in rabbits and its application to evaluate superantigen-adsorbing device

被引:7
作者
Fukuyama, M
Miwa, K
Shibayama, N
Ogura, S
Nishiyama, T
Maekawa, N
机构
[1] Toray Industries Ltd, Med Devices Res Lab, Specialty Mat Res Labs, Shiga 5200842, Japan
[2] Kagawa Med Univ, Ctr Emergency Med, Kagawa, Japan
[3] Kagawa Prefectural Hosp, Ctr Emergency Med, Kagawa, Japan
关键词
superantigen; toxic shock syndrome toxin 1; staphylococcus aureus; animal model; blood purification; adsorption; cecal ligation and puncture; multiple organ failure;
D O I
10.1159/000083206
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Background: Superantigens are suspected to be the potent and lethal pathogens of gram-positive sepsis, and a new therapy that targeted to superantigens are required. Methods: A mixed infection model was developed in rabbits by the cecal ligation and puncture associated with the intraperitoneal injection of Staphylococcus aureus, which produces toxic shock syndrome toxin 1 (TSST-1). Animals were also hemoperfused with a superantigen-adsorbing device (SAAD), or a control column. Results: The model animals revealed multiple organ failure and died 6-12 h after the injection of S. aureus. The plasma levels of TSST-1, but not of lipopolysaccharide (LPS), significantly (p < 0.01) and inversely correlated with mean arterial pressure (r = -0.63). Plasma TSST-1 level was significantly reduced and shock-onset time was significantly retarded in the SAAD treated group, although the survival time was not significantly affected. Conclusions: The animal model developed could serve as a model for sepsis. It is suggested that there is the potential application of SAAD in treating superantigen-related sepsis. Copyright (C) 2005 S. Karger AG, Basel.
引用
收藏
页码:119 / 127
页数:9
相关论文
共 24 条
[1]
Superantigen and endotoxin synergize in the induction of lethal shock [J].
Blank, C ;
Luz, A ;
Bendigs, S ;
Erdmann, A ;
Wagner, H ;
Heeg, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :825-833
[2]
GRAM-POSITIVE ORGANISMS AND SEPSIS [J].
BONE, RC .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (01) :26-34
[3]
INCIDENCE, RISK-FACTORS, AND OUTCOME OF SEVERE SEPSIS AND SEPTIC SHOCK IN ADULTS - A MULTICENTER PROSPECTIVE-STUDY IN INTENSIVE-CARE UNITS [J].
BRUNBUISSON, C ;
DOYON, F ;
CARLET, J ;
DELLAMONICA, P ;
GOUIN, F ;
LEPOUTRE, A ;
MERCIER, JC ;
OFFENSTADT, G ;
REGNIER, B .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (12) :968-974
[4]
Insulin sensitivity of glucose and fat metabolism in severe sepsis [J].
Chambrier, C ;
Laville, M ;
Berrada, KR ;
Odeon, M ;
Boulétreau, P ;
Beylot, M .
CLINICAL SCIENCE, 2000, 99 (04) :321-328
[5]
Staphylococcus aureus isogenic mutant, deficient in toxic shock syndrome toxin-1 but not staphylococcal enterotoxin A production, exhibits attenuated virulence in a tampon-associated vaginal infection model of toxic shock syndrome [J].
De Boer, ML ;
Kum, WWS ;
Chow, AW .
CANADIAN JOURNAL OF MICROBIOLOGY, 1999, 45 (03) :250-256
[6]
Animal models of sepsis and shock: A review and lessons learned [J].
Deitch, EA .
SHOCK, 1998, 9 (01) :1-11
[7]
Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis:: a randomised trial [J].
Levin, M ;
Quint, PA ;
Goldstein, B ;
Barton, P ;
Bradley, JS ;
Shemie, SD ;
Yeh, T ;
Kim, SS ;
Cafaro, DP ;
Scannon, PJ ;
Giroir, BP .
LANCET, 2000, 356 (9234) :961-967
[8]
One-way synergistic effect of low superantigen concentrations on lipopolysaccharide-induced cytokine production [J].
Luhm, J ;
Kirchner, H ;
Rink, L .
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 1997, 17 (04) :229-238
[9]
Sensitive enzyme-linked immunosorbent assays for the detection of bacterial superantigens and antibodies against them in human plasma [J].
Miwa, K ;
Fukuyama, M ;
Sakai, R ;
Shimizu, S ;
Ida, N ;
Endo, M ;
Igarashi, H .
MICROBIOLOGY AND IMMUNOLOGY, 2000, 44 (06) :519-523
[10]
RAPID ASSAY FOR DETECTION OF TOXIC SHOCK SYNDROME TOXIN-1 FROM HUMAN SERA [J].
MIWA, K ;
FUKUYAMA, M ;
KUNITOMO, T ;
IGARASHI, H .
JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (02) :539-542